Immunology & Rheumatology Clinical Trials

Statistical methods in immunology & rheumatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All immunology & rheumatology trials

1,062 results

• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 30NCT00927901
• Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 250NCT00733954
• EHPOCIndependent statistical analysis of Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04793750).Phase NAResults postedn = 224NCT04793750
• ELARAIndependent statistical analysis of Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 98NCT03568461
• ELEVATEIndependent statistical analysis of Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 292NCT00678587
• Elucidation of Acid-Induced Pulmonary Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Elucidation of Acid-Induced Pulmonary Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361972).Phase 2/3Results postedn = 17NCT00361972
• EmCyteIndependent statistical analysis of Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 90NCT03289416
• EMERALDIndependent statistical analysis of Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 33NCT05001737
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 977NCT02580591
• EMTIndependent statistical analysis of Enhanced Community-Based Asthma Monitoring Through Novel Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824936).Phase NAResults postedn = 15NCT05824936
• ENDEAVORIndependent statistical analysis of Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 929NCT01568866
• ENESTPathIndependent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.: primary endpoint results, effect estimate…Phase 3Results postedn = 620NCT01743989
• Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633215).Phase NAResults postedn = 36NCT02633215
• Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 66NCT01796470
• Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 31NCT00400686
• Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: Complete Statistical AnalysisIndependent statistical analysis of Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2/3Results postedn = 20NCT02018627
• Estrogen and Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Estrogen and Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03436992).Phase NAResults postedn = 143NCT03436992
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: Complete Statistical AnalysisIndependent statistical analysis of Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 101NCT00357500
• Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 19NCT02346877
• Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1/2Results postedn = 39NCT02865434
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: primary endpoint results, effect…Phase 3Results postedn = 262NCT01482767
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 87NCT04140695
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: primary endpoint results, effect estimate with…Phase 3Results postedn = 311NCT01498679
• Evaluating the Need for Pneumatic Compression Devices: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Need for Pneumatic Compression Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02641080).Phase NAResults postedn = 80NCT02641080
• Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 3,224NCT03164564
• Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 51NCT04915768
• Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults: primary endpoint results, effect estimate…Phase 1Results postedn = 124NCT03387150
• Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 956NCT01494038
• Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 51NCT06063603
• Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin’s Lymphoma (NHL) Weighing Less Than 70 Kilograms: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms: primary endpoint results, effect estimate with…Phase 4Results postedn = 61NCT01164475
• Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 250NCT00741390
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 188NCT05579730
• Evaluation of Diagnostic HIV Ag/Ab Combo Assay: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Diagnostic HIV Ag/Ab Combo Assay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00933933).Phase 3Results postedn = 635NCT00933933
• Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02322528).Phase NAResults postedn = 10NCT02322528
• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01730872).Phase 4Results postedn = 16NCT01730872
• Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02067039).Phase NAResults postedn = 2,665NCT02067039
• Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 68NCT03971539
• Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2/3Results postedn = 31NCT00999687
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 424NCT04146363
• Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 118NCT03600818
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 11NCT01534195
• Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 338NCT02164539
• Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 50NCT03353233
• EW-DIndependent statistical analysis of A Community Wellness Program for Adults Living With Long-term Physical Disability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 516NCT03653390
• Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: primary endpoint results, effect estimate with…Phase 2Results postedn = 2NCT03717480
• Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 8NCT02530515
• Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: Complete Statistical AnalysisIndependent statistical analysis of Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 74NCT05615935
• Extended Dosing With Eltrombopag for Severe Aplastic Anemia: Complete Statistical AnalysisIndependent statistical analysis of Extended Dosing With Eltrombopag for Severe Aplastic Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01891994).Phase 2Results postedn = 40NCT01891994
• Extension Study of IMO-8400 in Patients With Waldenström’s Macroglobulinemia Who Completed Study 8400-401: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1/2Results postedn = 5NCT02363439
• EXTRA-CVDIndependent statistical analysis of A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 298NCT03643705

← All therapeutic areas